ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)
Mitchell R. Smith,Chris Parker,Fred Saad,K. Miller,Bertrand Tombal,Quan Sing Ng,Martin Bögemann,В. Б. Матвеев,Josep M. Piulats,Luis Eduardo Rosa Zucca,Axel Heidenreich,Yoshiyuki Kakehi,A. Zhang,Heiko Krissel,Jiayu Shen,V. Wagner,Celestia S. Higano
出处
期刊：Annals of Oncology [Elsevier] 日期：2018-10-01卷期号：29: viii723-viii723被引量：16
PDF的下载单位、IP信息已删除
(2025-6-4)
BowieHuang
无极微光
你嵙这个期刊没买
幽壑之潜蛟
smottom
Twonej
CAOHOU
快乐滑板
Criminology34
toutou
猪猪hero
专注的问寒
eric888
pcr163
轨迹
CassieBotelho
pluto
沉默的倔驴
子车茗
拉哈80
YifanWang
zhonglv7
蜀安
xzy998
皖公网安备34019202002308
